Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Perrigo Company    PRGO

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 5 844 M
EBIT 2016 1 727 M
Net income 2016 945 M
Debt 2016 4 411 M
Yield 2016 0,51%
Sales 2017 6 183 M
EBIT 2017 1 844 M
Net income 2017 1 106 M
Debt 2017 3 536 M
Yield 2017 0,79%
P/E ratio 2016 20,26
P/E ratio 2017 17,14
EV / Sales 2016 3,12x
EV / Sales 2017 2,81x
Capitalization 13 843 M
More Financials
Company
Perrigo Co. Plc engages in the production of over-the-counter consumer goods and specialty pharmaceutical products.It operates through the following segments: Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals, and Specialty Sciences.The CHC segment includes... 
Sector
Pharmaceuticals
Calendar
05/12 | 12:00pmEarnings Release
More about the company
Surperformance© ratings of Perrigo Company
Trading Rating : Investor Rating :
More Ratings
Latest news on PERRIGO COMPANY
05/02DJActivist Investor to Pressure Stada AG to Explore Potential Sale -- Update
05/02DJActivist Investor to Pressure Stada AG to Explore Potential Sale Activist Inv..
04/30DJValeant Default Fears 'Cured' -- WSJ
04/29DJValeant Files Overdue Annual Report, Makes Sweeping Board Changes--Update
04/29DJValeant Files Overdue Annual Report, Makes Sweeping Board Changes--Update
04/29DJValeant Files Overdue Annual Report, Makes Sweeping Board Changes--Update
04/29DJValeant Files Overdue Annual Report, Resolving Risk of Default--Update
04/29DJValeant Files Overdue Annual Report, Resolving Risk of Default--Update
More news
Sector news : Pharmaceuticals - NEC
03:13a Covestro upbeat on manufacturing sector
02:01a Johnson & Johnson ordered to pay $55 million in talc-powder trial
01:44a JOHNSON & JOHNSON : to Appeal Jury Verdict in Cosmetic Talc Trial
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions